Asxc stock forecast.

Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, the Middle East, Africa, and Asia. About the company. ASXC fundamental analysis. Snowflake Score. Valuation.Asensus Surgical Stock Predictions for Dec 2025. In December 2025 analysts predict a stock price of $0.32. An increase of 24.94% compared to the previous month's estimate.Sydney Stock Market & Finance report, prediction for the future: You'll find the Telstra share forecasts, stock quote and buy / sell signals below. According to present data Telstra's TLS shares and potentially its market environment have been in bearish cycle last 12 months (if exists). The latest Asensus Surgical stock prices, stock quotes, news, and ASXC history to help you invest and trade smarter. Menu icon A vertical stack of three evenly spaced horizontal lines.1 Buy 0 Hold 0 Sell Based on 1 analysts giving stock ratings to Asensus Surgical in the past 3 months ASXC Stock 12 Months Forecast $2.00 (696.81% Upside) Based on 1 Wall …

1. BrainChip. Market cap: AU$318.3 million; current share price: AU$0.26. BrainChip (ASX: BRN) is the company behind akida, a revolutionary digital neuromorphic chip that’s built with a spiking neural …Asensus Surgical (ASXC) shares dipped 8% premarket on Monday after the medical device company provided 2022 year-end corporate update, guiding for revenue of ~$6.8M - $7.4MFind the latest Insider Activity data for Asensus Surgical, Inc. Common Stock (ASXC) at ... Forecast Changes ... An insider trading activity happens when corporate insiders trade in stock in their ...

Financial Performance In 2022, ASXC's revenue was $7.09 million, a decrease of -13.91% compared to the previous year's $8.23 million. Losses were -$75.56 …

ASXC Stock Chart & Stats. Advanced Chart > 1d 5d 3m-30.30%. 6m YTD 1y 3y 5y 10y. Day’s Range $0 - $0. 52-Week Range $0.20 - $1.18. Previous Close $0.23. Volume 766.95K. ... Forecast. 1Y Price Target. $2.00. Price Target Upside 747.46% Upside. Rating Consensus Moderate Buy. Number of Analyst Covering 1. Show more. …ASXC stock recorded 9/30 (30%) green days with 7.73% price volatility over the last 30 days. Based on our Asensus Surgical, Inc. stock forecast, it's now a bad time to buy ASXC stock because it's trading 0.75% above our forecast. Disclaimer: This is not investment advice. The information provided is for general information purposes only.Weather forecasts play an essential role in our daily lives, helping us plan our activities and stay prepared for any weather conditions that may come our way. One of the most common types of forecasts is the 7-day weather forecast, which p...2023/03/03 ... ... Asensus Surgical (NYSE:ASXC) shares dipped today on fourth-quarter results that came in mixed compared to the consensus forecast.

Get The Latest KSCP Stock Analysis, Price Target, Headlines, Short Interest at MarketBeat. Skip to main content. S&P 500 4,594.63. DOW 36,245.50. ... View our KSCP earnings forecast. When did Knightscope IPO? (KSCP) raised $224 million in an IPO on Thursday, January 27th 2022.

SinglePoint Inc () Stock Market info Recommendations: Buy or sell SinglePoint stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the SinglePoint share forecasts, stock quote and buy / sell signals below.According to present data SinglePoint's SING shares and potentially its market environment have been in a bullish …

Find the latest Asensus Surgical Inc (ASXC) stock forecast, 12-month price target, predictions and analyst recommendations.Asensus Surgical Inc. 0.2701. Delayed Data. As of Dec 01. +0.0114 / +4.41%. Today’s Change. 0.20. Today ||| 52-Week Range. 1.18.ASXC stock recorded 9/30 (30%) green days with 7.73% price volatility over the last 30 days. Based on our Asensus Surgical, Inc. stock forecast, it's now a bad time to buy ASXC stock because it's trading 0.75% above our forecast. Disclaimer: This is not investment advice. The information provided is for general information purposes only.Medical device business Asensus Surgical (NYSE: ASXC) is a company that’s in a time of transition. As InvestorPlace contributor Dana Blankenhorn pointed out, on March 5 the New York Stock ...Find the latest Earnings Report Date for Asensus Surgical, Inc. Common Stock (ASXC) at Nasdaq.com.

Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...Nov 30, 2023 · Analyst Forecast. According to 2 analysts, the average rating for ASXC stock is "Buy." The 12-month stock price forecast is $2.0, which is an increase of 673.10% from the latest price. Nov 24, 2023 · Asensus Surgical (ASXC) Stock Forecast and Price Target 2023 S&P 500 4,559.34 DOW 35,390.15 QQQ 389.51 12 crew members are missing, 1 dead after a cargo ship sinks off a Greek island in stormy seas [Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad) Detailed statistics for Asensus Surgical, Inc. (ASXC) stock, including valuation metrics, financial numbers, share information and more. Skip to main content. Log In …But as Hannans has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions. This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data. Show section.

As the former lithium division of FMC Corp., Livent has more than 60 years of experience in lithium production. The company went public on October 11, 2018 at $17 per share. Analyst Report: Livent ...

Asensus Surgical Inc (ASXC) stock has risen 6.69% while the S&P 500 is down -0.8% as of 12:13 PM on Thursday, Jan 19. ASXC is higher by $0.04 from the previous closing price of $0.62 on volume of 1,000,190 shares. Over the past year the S&P 500 is down -14.02% while ASXC is down -21.43%.Asensus Surgical, Inc. Reports Operating and Financial Results for the First Quarter 2023. Globe Newswire • 7 months ago. Track Asensus Surgical Inc (ASXC) Stock Price, …ASXC Stock 12 Months Forecast. $2.00. (747.46% Upside) Based on 1 Wall Street analysts offering 12 month price targets for Asensus Surgical in the last 3 months. The average price target is $2.00 with a high forecast of $2.00 and a low forecast of $2.00. The average price target represents a 747.46% change from the last price of $0.24.IFAN Financial Inc () Stock Market info Recommendations: Buy or sell IFAN Financial stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the IFAN Financial share forecasts, stock quote and buy / sell signals below.According to present data IFAN Financial's IFAN shares and potentially its market environment have …Market Average Movement. 8.8%. 10% most volatile stocks in AU Market. 17.4%. 10% least volatile stocks in AU Market. 3.2%. Stable Share Price: IPG is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 6% a week. Volatility Over Time: IPG's weekly volatility (6%) has been stable …See CORE LITHIUM LTD stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy. ... Forecast . Price target. 0.38 0.00 0.00%. The 9 analysts offering 1 year price forecasts for CXO have a max estimate of — and a min estimate of —.

ASXC Earnings Date and Information. Asensus Surgical last released its quarterly earnings data on August 10th, 2023. The reported ($0.09) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.08) by $0.01. The company earned $1.08 million during the quarter, compared to analyst estimates of $1.04 …

Nov 30, 2023 · About BrainChip Stock (ASX:BRN) BrainChip Holdings Ltd develops software and hardware accelerated solutions for artificial intelligence (AI) and machine learning applications in North America, Oceania, Europe, the Middle East, and Asia. The company primarily focus on development of Akida Neuromorphic Processor to provide ultra-low power and ...

But as Jindalee Lithium has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions. This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data. Show section.5,880,732. 0.12%. All the latest BHP Group (ASX:BHP) share price movements, news, expert commentary and investing advice from The Motley Fool Australia.Are you tired of spending countless hours manually tracking your inventory? Are you looking for a way to improve your decision making and forecasting processes? Look no further than a free inventory tracking template.Sydney Stock Market & Finance report, prediction for the future: You'll find the Origin Energy share forecasts, stock quote and buy / sell signals below. According to present data Origin Energy's ORG shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists).1. BrainChip. Market cap: AU$318.3 million; current share price: AU$0.26. BrainChip (ASX: BRN) is the company behind akida, a revolutionary digital neuromorphic chip that’s built with a spiking neural network, a type of artificial network that mimics the way messages are passed between neurons in the human brain.Buy 194 shares in this top ASX 200 dividend stock for $873 in passive income. This top ASX 200 dividend stock boosted its passive income payments after delivering $10.2 billion in FY 2023 profits.Get The Latest KSCP Stock Analysis, Price Target, Headlines, Short Interest at MarketBeat. Skip to main content. S&P 500 4,594.63. DOW 36,245.50. ... View our KSCP earnings forecast. When did Knightscope IPO? (KSCP) raised $224 million in an IPO on Thursday, January 27th 2022.5,880,732. 0.12%. All the latest BHP Group (ASX:BHP) share price movements, news, expert commentary and investing advice from The Motley Fool Australia.Stock Price Forecast. The 12 analysts offering 12-month price forecasts for Cresco Labs Inc have a median target of 2.65, with a high estimate of 12.35 and a low estimate of 1.25. The median ...

Allkem Stock Forecast, OROCF stock price prediction. Price target in 14 days: 5.851 USD. The best long-term & short-term Allkem share price prognosis for 2023, 2024 ...Find real-time ASX - ASE Technology Holding Co Ltd stock quotes, company profile, news and forecasts from CNN Business. Asensus Surgical Stock Forecast and Price Target. According to esteemed experts, the average price target for Asensus Surgical to reach this year is $2.25, …Instagram:https://instagram. fundrise income real estate fundbuy oil stocksstock simarm price TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.com1. BrainChip. Market cap: AU$318.3 million; current share price: AU$0.26. BrainChip (ASX: BRN) is the company behind akida, a revolutionary digital neuromorphic chip that’s built with a spiking neural network, a type of artificial network that mimics the way messages are passed between neurons in the human brain. state farm insurance for motorcyclewhat is the best appliance insurance Find the latest Asensus Surgical, Inc. ASXC analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range. ira roth account vs savings account The intrinsic value of one ASXC stock under the Base Case scenario is 0.0714 USD. Compared to the current market price of 0.2556 USD, Asensus Surgical Inc is ...Sydney Stock Market & Finance report, prediction for the future: You'll find the Brainchip Holdings share forecasts, stock quote and buy / sell signals below. According to present data Brainchip Holdings's BRN shares and potentially its market environment have been in bearish cycle last 12 months (if exists).Market Average Movement. 8.8%. 10% most volatile stocks in AU Market. 17.4%. 10% least volatile stocks in AU Market. 3.2%. Stable Share Price: IPG is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 6% a week. Volatility Over Time: IPG's weekly volatility (6%) has been stable …